1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Demographic and clinical characteristics of the study populationa
Characteristics
Patients (No.)151
Female (No.)46 (30.5%)
Age (mean) (yr)54.5 ± 19.5
MR-PTSE ≥50% (No.)40 (26.5%)
MR-PTSE <50% (No.)111 (73.5%)
CEI (No.)19 (12.6%)
MR-PTSE ≥50%, degenerative changes (No.)23 (15.2%)
MR-PTSE ≥50%, traumatic osseous retropulsion (No.)12 (8%)
MR-PTSE ≥50%, neoplastic (No.)3 (1.9%)
MR-PTSE ≥50%, hematoma (No.)1 (0.7%)
MR-PTSE ≥50%, infection (No.)1 (0.7%)
  • ↵a Results are expressed as absolute numbers (%) and mean.